Edenbridge Pharmaceuticals, LLC has recalled 4,548 bottles of Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine. The medication, packaged in 118 mL (4 Fl oz) bottles, is being recalled because it was found to be subpotent, meaning it contains less of the active ingredient than required. No incidents or injuries related to this recall have been reported to date.
Using subpotent medication may result in patients receiving a lower dose than intended, which could lead to ineffective treatment or potential withdrawal symptoms. If you have been taking this medication, contact your healthcare provider or pharmacist.
You have 2 options:
Rx only; Manufactured for Edenbridge Pharmaceuticals, LLC.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.